Bayer Aktiengesellschaft (OTCMKTS:BAYRY) Short Interest Update

Bayer Aktiengesellschaft (OTCMKTS:BAYRY) was the recipient of a large growth in short interest in the month of January. As of January 31st, there was short interest totalling 1,536,000 shares, a growth of 243.1% from the January 15th total of 447,700 shares. Based on an average trading volume of 2,008,300 shares, the short-interest ratio is currently 0.8 days.

Bayer Aktiengesellschaft Stock Up 2.9 %

BAYRY opened at $5.70 on Friday. The business has a 50 day moving average price of $5.24 and a two-hundred day moving average price of $6.43. Bayer Aktiengesellschaft has a 52 week low of $4.79 and a 52 week high of $8.58. The company has a market cap of $22.40 billion, a PE ratio of -21.92 and a beta of 1.04. The company has a quick ratio of 0.81, a current ratio of 1.32 and a debt-to-equity ratio of 1.19.

Bayer Aktiengesellschaft (OTCMKTS:BAYRY) last issued its quarterly earnings results on Tuesday, November 12th. The company reported $0.07 earnings per share for the quarter, missing the consensus estimate of $0.17 by ($0.10). Bayer Aktiengesellschaft had a positive return on equity of 16.90% and a negative net margin of 2.02%. The company had revenue of $10.96 billion for the quarter. As a group, research analysts anticipate that Bayer Aktiengesellschaft will post 1.31 EPS for the current year.

Bayer Aktiengesellschaft Company Profile

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy.